Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
To collect tumor, marrow specimens prospectively to study the molecular-genetic makeup of
individual neuroblastic tumor and its metastasis by blood and marrow, and to correlate these
findings with clinical outcome, and to relate the signaling circuitry of neuroblastic tumors
to that of embryonic neuroectodermal cells. .
Observational Model: Cohort, Time Perspective: Prospective
To study the molecular-genetic makeup and metastasis of neuroblastic tumors.
Before surgery and a maximum of 10 times
Nai-Kong Cheung, M.D., Ph.D.
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
|Memorial Sloan-Kettering Cancer Center||New York, New York 10021|